Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica, UK University Win 500K Grant to Implement Functional Annotation

NEW YORK, March 25 - The UK's LINK Applied Genomics Programme has awarded Inpharmatica and the University College London £500,000, or about $714,000, to create and maintain a 3D database of enzyme functional sites.
LINK is a UK government creation to "[promote] partnership in pre-competitive research" between industry and academia. The program in applied genomics itself is funded by the nation's Biotechnology and Biological Science Research Council, the Department of Trade and Industry, and the Medical Research Council. 

The grant will fund four post docs, two each at Inpharmatica and UCL, for three years. The UCL's efforts will be led by Janet Thornton, a professor who also happens to be the director of the European Bioinformatics Institute.


The Inpharmatica/UCL project, called Capturing Protein Functional Information from Structural Data: 3D Templates and Genome Annotation, will seek to collect genomic data and create an automated protein-site atlas of enzyme functional sites.


Mark Swindells, CSO of Inpharmatica, said that the partnership will first concentrate on enzyme sites but will move to other family-based structural data.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.